of its own funds on the construction of 2 pharmaceutical plants and a laboratory. By 2018 the company plans to spend RUB 17 bln. on the modernisation of its production processes. In 2014, Russia's VTB Bank extended a credit line for the FSUE SPA Microgen to the amount of RUB 2 bln., for a period of 3 years. The company is state-owned, but does not receive subsidies from the State budget. References 2003 establishments in Russia Manufacturing companies based in Moscow Vaccine producers Federal State Unitary Enterprises of Russia Rostec Pharmaceutical companies of Russia